Status:
COMPLETED
Therapeutic Effect of Methalazine on 27 Cases of Suppurative Hidradenitis
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Conditions:
Hidradenitis Suppurativa
Eligibility:
All Genders
Brief Summary
Background: Hidradenitis suppurativa (HS) is a chronic inflammatory relapsing disease involving the axillae, breast ,groin and anogenital regions. The therapies of the disease are diverse, including m...
Eligibility Criteria
Inclusion
- Recurrent painful or suppurative lesions
- Typical clinical manifestations: the distribution of apocrine sweat glands is deep in painful nodules, abscesses, sinuses, scars;
Exclusion
- Severe neurological and psychiatric diseases
- Tumor diseases
- Pregnant women in lactation period
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2023
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT06568224
Start Date
May 1 2020
End Date
September 1 2023
Last Update
September 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jiangsu Provincial People's Hospital
Nanjing, Nanjing, China, 210029